Mark E. Dunlap

6.3k citations
85 papers · 5.0k · 3 hit papers · h-index 32

Impact in

    • Heart Failure Treatment and Management
    • Cardiovascular Function and Risk Factors
    • Cardiovascular Health and Disease Prevention
    • Blood Pressure and Hypertension Studies
    • Cardiac pacing and defibrillation studies
    • Heart Rate Variability and Autonomic Control
    • Cardiac electrophysiology and arrhythmias
  • Nephrology top 2%

Papers in

    • Heart Failure Treatment and Management 33
    • Cardiovascular Function and Risk Factors 15
    • Heart Rate Variability and Autonomic Control 14
    • Cardiac electrophysiology and arrhythmias 8
    • Cardiac pacing and defibrillation studies 7
    • Cardiovascular Health and Disease Prevention 6
    • Potassium and Related Disorders 6

Mark E. Dunlap

85 papers receiving 4.8k citations

Mark E. Dunlap's Hit Papers

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial 2022 · 125 citations
1250+5+11Years since publication2505007501000

Peers

Mark E. Dunlap
Comparison fields: 5 of 145
  • Cardiology and Cardiovascular Medicine 3.1k
  • Nephrology 303
  • Endocrinology, Diabetes and Metabolism 403
  • Pulmonary and Respiratory Medicine 647
  • Complementary and alternative medicine 157
Replace Daniel M. Bloomfield with:
Daniel M. Bloomfield United States
Helmut Schumacher Germany
Nicola De Luca Italy
Katerina K. Naka Greece
Amos Katz Israel
Paul Leeson United Kingdom
Takashi Shimamoto Japan
Michael J. Koren United States
Sanjay Patel Australia
Neil Chapman United Kingdom
Mark E. Dunlap relative to Daniel M. Bloomfield United States Daniel M. Bloomfield's profile →
Citations per field
00.5×1.5×
Daniel M. Bloomfield · 1×
Citations per year

Countries citing papers authored by Mark E. Dunlap

Since Specialization
Citations

This map shows the geographic impact of Mark E. Dunlap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Dunlap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Dunlap more than expected).

Fields of papers citing papers by Mark E. Dunlap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Dunlap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Dunlap. The network helps show where Mark E. Dunlap may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Dunlap, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Dunlap Line = papers co-authored together Mark E. Dunlap links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
Hit paper breakdown →
20111018
2
MAD skills
Hit paper breakdown →
2009352
3 2004325
4 2011258
5 2015255
6 2006205
7 2001175
8 2012172
9 2007150
10 2007141
11 2021129
12
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
Hit paper breakdown →
2022125
13 2009100
14 199995
15 201695
16 200792
17 200684
18 201078
19 200875
20 200068

About Mark E. Dunlap

Mark E. Dunlap is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Complementary and alternative medicine, Endocrinology, Diabetes and Metabolism and Endocrine and Autonomic Systems, having authored 85 papers that have together received 5.0k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (33 papers), Cardiovascular Function and Risk Factors (15 papers), Heart Rate Variability and Autonomic Control (14 papers), Cardiac electrophysiology and arrhythmias (8 papers), Cardiac pacing and defibrillation studies (7 papers), Potassium and Related Disorders (6 papers), Cardiovascular Health and Disease Prevention (6 papers) and Cardiovascular and exercise physiology (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (3.1k citations), Nephrology (303 citations), Endocrinology, Diabetes and Metabolism (403 citations), Pulmonary and Respiratory Medicine (647 citations) and Complementary and alternative medicine (157 citations). Mark E. Dunlap has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Steven Bibevski, Paul A. Sobotka, Marc Alan Pfeffer, Jeffrey P. Cohen, Joseph M. Hellerstein, Gary F. Mitchell, J. Malcolm O. Arnold, Christopher Bull Granger, Bertil Olofsson and Eric L. Michelson. Their work appears in journals such as Journal of Cardiac Failure, Journal of the American College of Cardiology, European Journal of Heart Failure, Circulation and Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact